Field Trip plans to enters Oregon's medicinal market for psilocybin-assisted psychotherapy.
Field Trip plans to enters Oregon's medicinal market for psilocybin-assisted psychotherapy.
Oregon has legalized the medicinal use of psilocybin. Here is why that's big news for the psychedelic drug industry.
Pure Extracts Corp. is an extraction specialist targeting the cannabis, psychedelics and functional mushrooms sectors and will trade on the CSE under the symbol "PULL".
On the eve of the U.S. election, psychedelic drugs are a high-profile election issue.
This dosing study on LSD will be utilized as MindMed prepares for its Phase 2b clinical trial of LSD for anxiety.
With an industry-leading psychedelic drug R&D portfolio, MindMed has plenty of options to leverage its cash-on-hand to a higher share price.
With MindMed's latest financing, total cash reserves now stand at CAD$50.1 million.
Fitness wearables company, Hapbee Technologies, is going to commence trading October 30th on the TSX Venture Exchange (symbol "HAPB").
M2Bio Sciences (Wuhan General Group) has finalized an agreement with the University of Pretoria (South Africa) to conduct a psilocybin-based clinical trial.
Champignon Brands is hopeful that the B.C. Securities Commission is close to revoking its Cease Trade Order for SHRM.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now